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Objective:  The  TackSHS  project  aims  to comprehensively  elucidate  the  impact  that  exposure  to second-
hand smoke  (SHS)  from  cigarettes  and  second-hand  aerosols  (SHA)  from  electronic  cigarettes  have  on
the  respiratory  health  of the  European  population  according  to  socioeconomic  characteristics  and  other
determinants.
Method:  The  TackSHS  project  involves  a series  of  coordinated  studies  carried  out  by 11 academic  and
public  health  organisations  from  six  European  countries.  The  project  will  investigate:  a)  the determinants
of  SHS  and  SHA  exposure  assessed  at the  individual  level  (surveys  on  representative  general  population
samples)  and  in  common  environments  (environmental  sampling  in  speciﬁc  settings);  b)  the overall
disease  burden,  mortality  and  morbidity  attributable  to  such  exposure;  and c)  its economic  impact  in
terms  of  direct  health  care  costs.  The  project  will also examine  speciﬁc  acute  respiratory  health  changes
in  healthy  individuals  and  patients  with  respiratory  diseases  exposed  to SHS  and  SHA.  In addition,  the
project  will  examine  the  effectiveness  of a  novel  intervention  to  reduce  SHS  exposure  in households
where  smoking  is  permitted.  All  these  studies  are  inter-related  and involve  collaborative  coordination
among  the  participant  organisations.
Conclusion:  The  comprehensive,  integrated  approach  of the  TackSHS  project  will  enable  a  signiﬁcant
step  forward  from  the current  status  quo  in  the  understanding  of  the impact  of SHS  and  SHA  exposure
on  health  and  provide  the  basis  for  health  policy  recommendations  to help  European  countries  to  further
reduce  the harm caused  by SHS  and  SHA  exposure.
©  2019  SESPAS.  Published  by Elsevier  Espan˜a,  S.L.U.  This  is  an  open  access  article  under  the  CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Abordando  la  exposición  a  las  emisiones  del  tabaco  y  de  los  cigarrillos
electrónicos:  protocolo  del  proyecto  TackSHS
Palabras clave:
Humo ambiental del tabaco
Tabaquismo pasivo
Cigarrillos electrónicos
Sistemas electrónicos de administración
de nicotina
r  e  s  u  m  e  n
Objetivo:  El  proyecto  TackSHS  pretende  caracterizar  el  impacto  global  de  la  exposición  al  humo  ambiental
de tabaco  (HAT)  y  al  aerosol  de los cigarrillos  electrónicos  (ACE)  en  la salud  respiratoria  de la  población
europea  según  variables  socioeconómicas  y otros  determinantes.
Método:  El  proyecto  TackSHS  consiste  en  una  serie  de  estudios  coordinados  y gestionados  por  11 organiza-
ciones  académicas  y  de  salud  pública  de  seis  países  europeos.  El  proyecto  estudiará:  a)  los determinantes
de  la  exposición  al  HAT  y  al  ACE  a nivel  individual  (encuestas  en  muestras  representativas  de  la  población
general)  y  en espacios  comunes  (muestras  ambientales  en  lugares  especíﬁcos);  b)  su  carga  general  de
∗ Corresponding author.
E-mail address: efernandez@iconcologia.net (E. Fernández).
♦ See Annex.
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0213-9111/© 2019 SESPAS. Published by Elsevier Espan˜a, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
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Exposición al aerosol
Salud respiratoria
Carga de enfermedad
Impacto económico
enfermedad  y  la  morbimortalidad  atribuible  a  tal  exposición;  y c) su  impacto  económico  en  términos  de
costes  sanitarios  directos  e indirectos.  Además,  el  proyecto  investigará  cambios  especíﬁcos  a corto  plazo
en  la  salud  respiratoria  en  personas  sanas  y en  pacientes  con  enfermedades  respiratorias  expuestos  al
HAT  y  al  ACE.  También  examinará  la  efectividad  de una  intervención  novedosa  para  reducir  la  exposición
al HAT  en  hogares  donde  se  permite  fumar.  Todos  estos  estudios  están  interrelacionados  y conllevan  una
coordinación  colaborativa  entre  las instituciones  participantes.
Conclusión:  El  enfoque  integral  del proyecto  TackSHS  permitirá  un  avance  signiﬁcativo  en  la evidencia
sobre la comprensión  del impacto  de  la  exposición  al  HAT y al  ACE  en  la  salud,  y proporcionará  una  base
para desarrollar  recomendaciones  políticas  sanitarias  para  ayudar  a los  países  europeos  a reducir  los  dan˜os
causados  por  la  exposición  al  HAT  y al  ACE.
©  2019  SESPAS.  Publicado  por Elsevier  Espan˜a,  S.L.U.  Este  es  un  artı´culo  Open  Access  bajo  la licencia  CC
BY-NC-ND  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Research produced during the past three decades has provided
substantial evidence of the harm that short- and long-term expo-
sure to second-hand smoke (SHS) represents to respiratory and
cardiovascular health of adults and children.1,2 While interest in
SHS exposure prevalence and its effects is increasing,3 important
gaps remain when designing national and international health poli-
cies aiming to protect populations. One of them is a scarcity of
studies objectively measuring markers of SHS in settings where
smoking is not regulated, such as private and outdoor public places.
In addition, electronic cigarettes (e-cigarettes) have irrupted
into the market of tobacco products in the past decade, creat-
ing an on-going debate among the research community on their
health effects and potential impact on public health.4 While active
e-cigarette use and its health effects have received substantial
attention in research, evidence on the health impact of bystanders’
exposure to second-hand aerosols (SHA) generated by its use is still
scarce.5
The project “Tackling secondhand tobacco smoke and e-
cigarette emissions: exposure assessment, novel interventions,
impact on lung diseases and economic burden in diverse European
populations” (the TackSHS project: www.tackshs.eu) was devel-
oped to address these and other challenges in the research of SHS
and SHA. The TackSHS project intends to comprehensively eluci-
date the impact that SHS and SHA exposure have on the European
population and how health impacts vary according to socioeco-
nomic and other demographic characteristics, with a particular
emphasis on speciﬁc vulnerable groups. This paper describes the
speciﬁc objectives and methods of each study or ‘work-package’
within the project.
Method
The TackSHS project is organised in 11 work-packages (WP) of
which eight are research-oriented and correspond to independent
studies, with a further three WPs  involved in providing support
(coordination, instrument calibration, and results dissemination)
during the 48 months of the project (November 2015 – October
2019). The overall structure of the project is depicted in Figure 1.
A summary of the WPs  with the leading partners is provided in
Table I of the online Appendix.
Study 1. Environmental assessment of SHS exposure in private
and outdoor settings in Europe (WP2)
This is a European cross-sectional study, led by the Agència de
Salut Pública de Barcelona (Spain), that aims to objectively assess
SHS exposure across a range of different environments where
smoking was not regulated at the time this project was planned.
The study will be conducted in 11 European countries (Bulgaria,
France, Germany, Greece, Ireland, Italy, Poland, Portugal, Roma-
nia, Spain and the United Kingdom) representing geographical,
legislative (country-speciﬁc smoke-free policies) and cultural vari-
ations across the European Union (EU). Private settings studied will
include homes and cars, while outdoor settings will include ter-
races of hospitality venues, children playgrounds and entrances
to primary school buildings. Around 1000 environmental mea-
surements will be collected: 180 measurements from homes in
9 countries and 660 measurements from outdoor settings in the
11 countries involved in the study; and 120 environmental mea-
surements will be collected in cars in two countries (Spain and the
United Kingdom). These countries were selected considering dif-
ferences in smoking legislation in cars. A convenience sample will
be obtained considering neighbourhoods from different socioeco-
nomic status, which will be assessed using local ecological synthetic
indexes. SHS will be assessed through the measurement of airborne
nicotine. Nicotine samplers, which consist of a 37-mm diameter
plastic cassette containing a ﬁlter treated with sodium bisulphate,
will be used. A passive sampling will be performed in homes (7-
day sampling) and cars (24-hour sampling). In outdoor settings,
active sampling will be used attaching a nicotine sampler to an air
pump with a ﬂow rate of 3 L/min, and 30-min measurements will
be taken. Sampling will be done avoiding the warmest and the cold-
est months of the year. All the nicotine samples will be analysed by
gas chromatography/mass spectrometry.6
Study 2. The TackSHS survey: a pan-European study on SHS and
SHA exposure (WP3)
This is a European cross-sectional study, led by the Istituto
di Ricerche Farmacologiche Mario Negri IRCCS (Italy), that aims
to: 1) estimate the prevalence and the determinants of smok-
ing, e-cigarette use, and exposure to SHS and SHA; 2) analyse
attitudes, perceptions and behaviours of the adult European pop-
ulation towards smoke-free policies in their countries; and 3)
compare selected smoking-related data originated in this study
and a previously conducted pan-European survey (i.e., the PPACTE
project).7 Approximately 12,000 individuals aged 15 years and
older will be enrolled in 12 EU countries (the same countries listed
for WP2  plus Latvia). The TackSHS survey will be representative of
the country-speciﬁc population using a similar methodology of a
previous project.7 The sample size in each speciﬁc country (approx-
imately n = 1000) will enable the estimation of prevalence in that
country with a standard error of ± 1.6%. The sampling methodology
(in most of the countries multistage/stratiﬁed random sampling)
will ensure the representativeness of the adult population in terms
of sex, age, geographic area and selected socioeconomic charac-
teristics. A standard questionnaire developed ad hoc from existing
validated questionnaires will be used to collect information on
cigarette smoking, use of e-cigarettes and emergent heated tobacco
products. The questionnaire focuses particularly on the exposure
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Figure 1. TackSHS project structure and organisation of the work packages (WPs). SHS: Secondhand smoke; e-cig: electronic cigarettes.
to SHS and the passive exposure to SHA from e-cigarettes in differ-
ent indoor and outdoor settings. WP3  will also examine compliance
with the current country-speciﬁc smoke-free legislations, attitudes
and perceptions towards various tobacco control policies, including
smoking ban regulations that are already adopted, and an extension
of these regulations to other (outdoor) public places. Finally, the
survey will explore participants’ knowledge of the harmful effects
of SHS and SHA.
Study 3. Air quality feedback to reduce SHS exposure in homes
(WP4)
This is an intervention study, led by the University of Stirling
(Scotland, UK), aiming to encourage behaviour-change towards a
smoke-free home environment. The study will provide the par-
ticipants (smokers who smoke at home and take care of at least
one child) regular feedback in the form of personalised air qual-
ity measurements made in their homes. This study will develop
a targeted intervention with socioeconomically deprived smok-
ers in four countries (Greece, Italy, Scotland, and Spain) based on
a previously piloted intervention.8 The study will aim to recruit
160 smokers (40 in each country). Participants will have particle
counting instruments to measure in real time particulate matter
concentration (PM2.5) installed in their homes for a period of 30
days. These devices will allow data acquisition in real-time with a
3G internet connection. During this period, personalised feedback
will be provided to, and discussed with, the smoker along with
target-setting and exploration of suitable methods of behaviour-
change. Personalised feedback will be given via text messages to
mobile phones, email messages and through telephone calls. A
ﬁnal home visit will gather data on changes made while some
participants (10-20%) will take part in a further qualitative phone
interview to gather data on their experience of the intervention.
Study 4. Health effects of SHS exposure in outdoor smoking areas
in patients with COPD and asthma (WP5)
This is a clinical research study, led by TobaccoFree Research
Institute Ireland, aiming to assess the acute respiratory health
effects that result from short-term SHS exposure among patients
with asthma and chronic obstructive pulmonary disease (COPD).
In many European countries, the introduction of smoke-free laws
has prompted the proliferation of outdoor areas where smoking
is permitted, and there exist places where non-smokers are still
exposed to some levels of SHS. The health effects of such expo-
sures are uncertain as to date there is only anecdotal evidence;
some effects can be expected but it may  be difﬁcult to demonstrate
unless in naturalistic, real-life conditions. This study will aim to
involve 60 patients (volunteers) from three European countries: the
Czech Republic, Ireland, and Spain (20 patients in each participat-
ing country: 10 COPD and 10 asthma patients). The recruitment of
such patients will be done with the cooperation of patients’ organ-
isations in these countries which are afﬁliated with the European
Lung Foundation. Participants will be trained to keep a diary record
of any noted changes and medication usage and perform pre- and
post-peak ﬂow, spirometry, and carbon monoxide measurements.
Such patients will wear personal monitors to continuously measure
exposure to particulate matter (PM1, PM2.5, PM10) with continu-
ous geolocalisation monitoring with AirSpeck mobile wireless air
quality monitors and a RESpeck monitor to measure breathing rate
and depth to detect any acute changes in breathing during or fol-
lowing exposure to SHS at entertainment facilities. These novel
measurements will determine the individual level of SHS exposure
with spatially-resolved estimation of personal dosage of PM and
the identiﬁcation of acute respiratory effects from such exposure.
There is also a recording of each breath sound which can be recog-
nised and matched with time, location and level of exposure with
identiﬁcation of any lags in time that may  occur.
Study 5. Impact of short-term second-hand exposure
to e-cigarette aerosols (SHA) on the respiratory system (WP6)
This study, led by the Hellenic Cancer Society (Greece), is aimed
at characterizing exposure to e-cigarette aerosols among healthy
non-smoker volunteers. An experimental study with cross-over
design will be implemented in a laboratory. Three trial arms will
be performed (no exposure vs. low e-cigarette aerosol exposure
vs. high e-cigarette aerosol exposure) that will be differentiated
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by the e-cigarettes’ battery power outputs. The study sample
will consist of 40 adult volunteers that will be randomized to
the sequence of three exposures to e-cigarette aerosol. In total,
120 person-exposures will take place, leading to 240 pre- and post-
measurements. Recruitment will take place in Athens (Greece).
Exposures will last 30 minutes and will take place in a standardised
exposure chamber.9 Before and after exposure to aerosols origi-
nated from e-cigarette use, the lung function of each participant
will be assessed through impulse oscillometry to assess respira-
tory system impedance and resistance, exhaled nitric oxide levels
and 8-isoprostane concentration in the exhaled breath condensate
as a marker of oxidative stress.10
Study 6. Second-hand exposure to emissions from electronic
cigarettes: personal and environmental assessment in conﬁned
spaces (WP8)
This WP,  led by the Institut Català d’Oncologia (Spain),
comprises three sub-studies to address three complementary
objectives. Firstly, a systematic review of the published studies
on passive exposure to e-cigarette aerosols will be performed.
Secondly, environmental and bystanders’ exposure to e-cigarette
aerosols in controlled conditions in a car and a room will be inves-
tigated through an experimental study which will involve two
volunteers exposed to SHA and an e-cigarette user to produce it.
Airborne nicotine and PM2.5 will be measured for environmental
exposure and nicotine, cotinine and tobacco-speciﬁc nitrosamines
in saliva for personal exposure assessment. Thirdly, a cross-
sectional study will be conducted to investigate environmental and
bystanders’ exposure to SHA in real-life conditions at homes of e-
cigarette users, in four European countries (Greece, Italy, Spain,
and the UK). Based on the differences detected in a previous pilot
study11 and standard assumptions, this study will aim to include
250 participants. Airborne nicotine and PM2.5 will be measured
during one week and saliva and urine samples will be collected
for the determination of nicotine, cotinine and tobacco-speciﬁc
nitrosamines. Airborne nicotine samples will be analysed by gas
chromatography/mass spectrometry;6,12 while saliva and urine
analysis will be performed using high-resolution chromatogra-
phy/mass spectrometry;13,14 and PM2.5 will be measured by means
of an optical portable counter.15
Study 8. Attributable mortality and morbidity to SHS in Europe
(WP9)
The objectives of this WP,  led by the Istituto per lo Studio,
la Prevenzione e la Rete Oncologica (Italy), are: 1) to review the
methods used in the literature, with special focus on Europe, to cal-
culate attributable mortality and morbidity to SHS and the results
published to date for EU countries; 2) to develop algorithms of cal-
culation of attributable mortality and morbidity to SHS; and 3) to
update attributable mortality and morbidity to SHS for EU countries
based on SHS exposure prevalence collected in the WP3.
In order to estimate attributable mortality and morbidity to SHS,
mortality and morbidity data (asthma, COPD, lung cancer, stroke,
ischaemic heart disease, breast cancer and diabetes in adults; low
birth weight, lower respiratory infections, otitis media, asthma and
sudden infant death syndrome in children) will be collected from
28 EU countries on SHS-related diseases, along with information
on prevalence of SHS exposure in EU countries. For attributable
mortality and morbidity estimates, data on the prevalence of SHS
exposure will be used from two sources: information collected in
the WP3  of this project and from Eurobarometer surveys. Finally,
sensitivity analyses of attributable mortality and morbidity to SHS
will be conducted.
Study 9: Economic impact of SHS on morbidity and mortality and
return on investment of interventions aiming at reducing SHS
exposure (WP10)
This study, led by the Universidad Politécnica de Cartagena
(Spain), will produce economic models for the analysis of the return
on investment of policies aimed at reducing SHS exposure in EU
countries. Available return on investment models for smoking ces-
sation interventions (http://www.equipt.eu) will be considered.
Nevertheless, these models consider the effects of SHS exposure by
assuming that each successful quit contributes a fractional reduc-
tion in the disease burden associated with SHS, they do not include
policies speciﬁcally aimed at reducing SHS other than curbing
smoking prevalence. The information on SHS exposure in European
countries obtained in the WP3  and the epidemiological evidence on
attributable mortality and morbidity to SHS obtained in the WP9
will be combined with data on the cost consequences of disease
to obtain country-speciﬁc versions of the return on investment
models. The models will consider the lag between exposure and
effect and therefore will use appropriate short- and medium-term
horizons (2, 5, and 10 years) and long-term horizons (20 years and
lifetime). With these models, the economic burden caused by SHS
exposure and the return on investment of some interventions will
be estimated. Different perspectives (health system, overall pub-
lic sector and wider society) will be adopted. The model outcomes
will comprise not only standard cost-effectiveness and cost-utility
ratios but also a fully disaggregated list of health outcomes and
resource use consequences so that the budgetary impact of imple-
mentation at local, regional and national scale will be appraised.
Supportive WP:  Instruments’ calibration (WP7)
This WP,  led by the Fondazione IRCCS Istituto Nazionale dei
Tumori (Italy), will investigate the best methods and procedures
for real-time measurement of SHS and SHA using optical particle
counters. All devices of the project Partners used in WP4, WP5, WP6
and WP8  (Dylos DC1700, SidePak AM150, and AirVisual Pro) will
be tested and individually calibrated through comparison with one
Beta Attenuation Monitor (BAM-1020).
The Dylos DC1700 is an optical particle counter instrument that
counts the small and large particles present in the surrounding
environment. The TSI SidePak AM510 Personal Aerosol Monitor
is a laser photometer that measures a variety of particle sizes
(PM1, PM2.5, PM10). The AirVisual Pro is a low-cost optical parti-
cle counter, measuring PM2.5, PM10, carbon dioxide, temperature
and relative humidity. All these devices are portable and station-
ary, capable to operate and memorise the data with or without
connection to the internet.
For calibration, comparison of different measurements will
be performed by the generation of exposures using a range of
cigarettes and e-cigarettes in a real-life environment in a room
of 48 m3. The BAM-1020 will be operated and the optical parti-
cle counters will be calibrated in parallel for the time necessary
to simulate concentration changes in order to verify the accuracy
and precision of the instruments within the whole range of mea-
surements speciﬁed by the manufacturers and to compensate for
coincidence losses.
Conclusion
The TackSHS project involves a comprehensive and innovative
approach to develop a scientiﬁc understanding of second-hand
exposure to smoke from cigarettes and aerosols from e-cigarettes.
For the ﬁrst time, this project will consider the integration of
data on SHS exposure from a validated, homogenous survey, as
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an instrument for the subjectively perceived exposure by wide
populations in several EU countries, together with its objective
assessment using environmental and biological markers. Whilst
this is the core objective of the TackSHS project, additional WPs
will address speciﬁc questions regarding exposure to SHS and SHA,
including its impact on health and its economic burden in spe-
ciﬁc populations and patients with chronic lung and respiratory
diseases.
At the societal level, we aim to raise awareness of the risks from
SHS exposure and their associated health burden. The project will
also provide new evidence to further inform the debate about the
scale of risk from SHA exposure. TackSHS team will also invest con-
siderable effort in disseminating the obtained results, not only to
the scientiﬁc community, policy makers and stakeholders, but also
to patient and consumer organisations at the national and European
level.
The initial publication plan includes 20 papers with the main
ﬁndings, considered as priority publications. Further publications,
with results at the country level and combining the results from
different studies will be produced after the initial primary publica-
tions. In addition, a comprehensive report, as well as policy briefs,
will be launched in the ﬁnal conference and distributed to stake-
holders, including policymakers, patients, the scientiﬁc community
and the general public.
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